AU7726598A - Modification of platelet action by fibrinogen-coated particles - Google Patents

Modification of platelet action by fibrinogen-coated particles

Info

Publication number
AU7726598A
AU7726598A AU77265/98A AU7726598A AU7726598A AU 7726598 A AU7726598 A AU 7726598A AU 77265/98 A AU77265/98 A AU 77265/98A AU 7726598 A AU7726598 A AU 7726598A AU 7726598 A AU7726598 A AU 7726598A
Authority
AU
Australia
Prior art keywords
fibrinogen
modification
coated particles
platelet action
platelet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77265/98A
Inventor
John D. Vickers
Richard C.K. Yen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemosphere Inc
Original Assignee
Hemosphere Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemosphere Inc filed Critical Hemosphere Inc
Publication of AU7726598A publication Critical patent/AU7726598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU77265/98A 1997-06-05 1998-06-04 Modification of platelet action by fibrinogen-coated particles Abandoned AU7726598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4874797P 1997-06-05 1997-06-05
US60048747 1997-06-05
PCT/US1998/011677 WO1998055455A2 (en) 1997-06-05 1998-06-04 Modification of platelet action by fibrinogen-coated particles

Publications (1)

Publication Number Publication Date
AU7726598A true AU7726598A (en) 1998-12-21

Family

ID=21956241

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77265/98A Abandoned AU7726598A (en) 1997-06-05 1998-06-04 Modification of platelet action by fibrinogen-coated particles

Country Status (2)

Country Link
AU (1) AU7726598A (en)
WO (1) WO1998055455A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616311A (en) * 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
US5691160A (en) * 1992-08-14 1997-11-25 Biogen, Inc. Effects of actin filaments of fibrin clot structure and lysis

Also Published As

Publication number Publication date
WO1998055455A2 (en) 1998-12-10
WO1998055455A3 (en) 1999-03-04
WO1998055455A9 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
EP0694552A3 (en) The preparation of sulfur-containing organosilicon compounds
AU1211397A (en) Shampoo composition containing capsules or particles
AU2597500A (en) Method of forming meltblown webs containing particles
AU1289199A (en) Articles or compositions comprising nanoscale particles; methods of utilizing orproducing such particles
AU7499098A (en) Suspension package
AU1252499A (en) Control of biofilm formation
AU4822499A (en) Making particulates of controlled dimensions
IL132532A (en) Intermediates for the preparation of substituted cephalosporins
AU5703399A (en) Promoters of neural regeneration
PL341049A1 (en) Agglomerates of particles
AU4715696A (en) Astaxanthin suspension
AU3208099A (en) Modification of metallic particles
AU5405496A (en) Manufacture of bags
AU5436196A (en) Fibrinogen-coated liposomes
AU4631499A (en) The preparation of arylphosphines
AU7726598A (en) Modification of platelet action by fibrinogen-coated particles
AUPP385598A0 (en) Purification of antibodies
AU4844696A (en) Mineral preparation containing coral sand or corallite
AU1101697A (en) Electromagnetic accelerometer
AU2041799A (en) Composition of adsorbent
AU8102498A (en) Preparation of diaryl-benzopyrans
AU4177796A (en) Particles containing perfume
AU5335198A (en) Powder separation
AU8892298A (en) Method of producing powder materials
AU8631198A (en) Method of altering the domains of cyclosporin synthetase to give a modified cyclosporin synthetase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase